Review
Published on 29 Jul 2022
Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.913231
- 5,923 views
- 9 citations
Type at least 3 characters
2,924 articles
Articles
Original Research
Published on 28 Jul 2022
Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.955186
- 3,992 views
- 4 citations
Case Report
Published on 28 Jul 2022
Uterine perivascular epithelioid tumors (PEComas) with lung metastasis showed good responses to mTOR and VEGFR inhibitors: A case report
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.797275
- 2,578 views
- 3 citations
Original Research
Published on 28 Jul 2022
A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.939343
- 1,832 views
- 7 citations
Original Research
Published on 28 Jul 2022
Monocarboxylate transporter upregulation in induced regulatory T cells promotes resistance to anti-PD-1 therapy in hepatocellular carcinoma patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.960066
- 2,756 views
- 7 citations
Review
Published on 28 Jul 2022
Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.911410
- 4,081 views
- 20 citations
Original Research
Published on 28 Jul 2022
Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.959595
- 2,794 views
- 19 citations
Original Research
Published on 28 Jul 2022
A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity via Inactivating PI3K/AKT and β-Catenin Pathways in Anaplastic Thyroid Carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.854702
- 1,404 views
- 1 citation
Review
Published on 27 Jul 2022
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.931774
- 8,045 views
- 20 citations
Original Research
Published on 27 Jul 2022
Heparanase regulates EMT and cancer stem cell properties in prostate tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.918419
- 2,265 views
- 5 citations
Editorial
Published on 27 Jul 2022
Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.938557
- 1,257 views
- 1 citation
Systematic Review
Published on 25 Jul 2022
The metabolic addiction of cancer stem cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.955892
- 4,531 views
- 9 citations
Review
Published on 25 Jul 2022
RET signaling pathway and RET inhibitors in human cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.932353
- 13,663 views
- 36 citations
Original Research
Published on 25 Jul 2022
Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.927358
- 3,020 views
- 7 citations
Original Research
Published on 25 Jul 2022
Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.809847
- 5,686 views
- 5 citations
Original Research
Published on 25 Jul 2022
Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.911316
- 2,877 views
- 6 citations